- Biomarkers in immunoglobulin light chain amyloidosis2017 | First Faculty of Medicine
- Long-Term outcomes of patients with light chain amyloidosis AL afterrenal transplantation with or without stem cell transplantation.Commentary on:NDT 26,2011,2032-20362011 | First Faculty of Medicine
- Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis2021 | Faculty of Medicine in Pilsen
- Magnetic resonance imaging in myocardial amyloidosis2019 | Faculty of Medicine in Pilsen
- Search for AL amyloidosis risk factors using Mendelian randomization2021 | Faculty of Medicine in Pilsen
- Genetic predisposition for multiple myeloma2020 | Faculty of Medicine in Pilsen
- Research Report University Hospital clinical trial AC-004-EUPublication without faculty affiliation
- Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-62022 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Czech Registry of Monoclonal Gammopathies - Technical Solution, Data Collection and Visualisation2017 | Publication without faculty affiliation
- Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes2022 | First Faculty of Medicine
- ATTR-ACT Study: breakthrough in the treatment of transthyretin cardiac amyloidosis2019 | First Faculty of Medicine, Central Library of Charles University